In 2018, Dr. Trimble was nominated to lead the US government’s participation in the new World Health Organization’s global initiative for cervical cancer prevention and control. This role builds upon Dr. Trimble’s previous position, as the founding Director of NCI’s Center for Global Health (CGH) in 2011. Under Dr. Trimble’s leadership the NCI CGH became the coordinating point for NCI’s work to strengthen global cancer research, to train future generations of global cancer researchers, and to help translate research into policy for cancer control. From 1991 to 2011 Dr. Trimble worked in NCI’s Division of Cancer Treatment and Diagnosis, with responsibility for national and international NCI-sponsored treatment trials in gynecologic cancer. He spearheaded the NCI’s Clinical Announcements regarding chemoradiation for cervical cancer (1999) and intraperitoneal chemotherapy for ovarian cancer (2006), both of which changed the standard of care for women with gynecologic cancer.